Male breast cancer risk study: building a comparison group
Part of Cancer, Skin clinical trials.
This study is building a comparison group of healthy men to help researchers understand genetic factors related to male breast cancer. If you are a healthy man age 66 or older with a family history of a specific genetic change but you do not carry that change yourself, you may be able to take part.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 66 or older.
- You have never had cancer.
- You are registered in the IUCT-O oncogenetics database as a relative of someone who carries a disease-causing genetic change in a cancer-predisposition gene.
- You have had a genetic counseling appointment at IUCT-O and do not carry the family's genetic change.
- You are not related to someone in the MATADOR1 study.
- You have an archived blood sample available for research and have given consent to use it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for men who have a known inherited gene change that raises their prostate cancer risk. It aims to help prevent or detect prostate cancer earlier, and you may be asked to undergo MRI and other study steps.
This study follows people who carry a harmful BRCA1 or BRCA2 gene mutation, whether or not they currently have breast or ovarian cancer. The goal is to better understand cancer risk over time and how being a carrier may affect screening and care.
This study looks at how men with a BRCA1/2 gene change make decisions about their health and prostate cancer risk. Participants will fill out surveys to help researchers understand these choices.
This study looks at your personal and family risk for prostate cancer and helps decide who should have extra screening like MRI. It may help you find cancer earlier if you are at higher genetic risk.
This trial looks at how inherited risk (family history or gene findings) relates to screening and treatment for prostate cancer. If you qualify, you may be offered prostate screening tests and follow-up to see how well risk information predicts next steps.
This study aims to find prostate cancer early in men who have a genetic predisposition (inherited genetic mutations or strong family history) that puts them at higher risk. The goal is to detect it sooner, when treatment may be more effective.
Hear when a new Male Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.